Nrx Pharmaceuticals Stock Market Value
| NRXP Stock | USD 1.19 0.02 1.65% |
| Symbol | NRX |
NRX Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NRX Pharmaceuticals. If investors know NRX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NRX Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Return On Assets (1.16) | Return On Equity (6.83) |
The market value of NRX Pharmaceuticals is measured differently than its book value, which is the value of NRX that is recorded on the company's balance sheet. Investors also form their own opinion of NRX Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NRX Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NRX Pharmaceuticals' market value can be influenced by many factors that don't directly affect NRX Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NRX Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NRX Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NRX Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NRX Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NRX Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NRX Pharmaceuticals.
| 11/11/2024 |
| 12/11/2024 |
If you would invest 0.00 in NRX Pharmaceuticals on November 11, 2024 and sell it all today you would earn a total of 0.00 from holding NRX Pharmaceuticals or generate 0.0% return on investment in NRX Pharmaceuticals over 30 days. NRX Pharmaceuticals is related to or competes with Biomx, Lexaria Bioscience, Aditxt, Nutriband, Quoin Pharmaceuticals, Longeveron LLC, and RenovoRx. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of cen... More
NRX Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NRX Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NRX Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 19.8 | |||
| Value At Risk | (6.12) | |||
| Potential Upside | 6.51 |
NRX Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NRX Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NRX Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use NRX Pharmaceuticals historical prices to predict the future NRX Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NRX Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NRX Pharmaceuticals Backtested Returns
NRX Pharmaceuticals has Sharpe Ratio of -0.16, which conveys that the firm had a -0.16% return per unit of standard deviation over the last 3 months. NRX Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NRX Pharmaceuticals' Market Risk Adjusted Performance of (0.37), mean deviation of 2.83, and Risk Adjusted Performance of (0.08) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NRX Pharmaceuticals will likely underperform. At this point, NRX Pharmaceuticals has a negative expected return of -0.58%. Please make sure to verify NRX Pharmaceuticals' potential upside and day median price , to decide if NRX Pharmaceuticals performance from the past will be repeated at some future point.
Auto-correlation | -0.48 |
Modest reverse predictability
NRX Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between NRX Pharmaceuticals time series from 11th of November 2024 to 26th of November 2024 and 26th of November 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NRX Pharmaceuticals price movement. The serial correlation of -0.48 indicates that about 48.0% of current NRX Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NRX Pharmaceuticals lagged returns against current returns
Autocorrelation, which is NRX Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NRX Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of NRX Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that NRX Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NRX Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NRX Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NRX Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NRX Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
NRX Pharmaceuticals Lagged Returns
When evaluating NRX Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NRX Pharmaceuticals stock have on its future price. NRX Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NRX Pharmaceuticals autocorrelation shows the relationship between NRX Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in NRX Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with NRX Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NRX Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with NRX Stock
Moving against NRX Stock
| 0.77 | BMY | Bristol Myers Squibb | PairCorr |
| 0.76 | GILD | Gilead Sciences | PairCorr |
| 0.64 | ESPR | Esperion Therapeutics | PairCorr |
| 0.45 | DNA | Ginkgo Bioworks Holdings | PairCorr |
| 0.44 | FLGC | Flora Growth Corp | PairCorr |
The ability to find closely correlated positions to NRX Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRX Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRX Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRX Pharmaceuticals to buy it.
The correlation of NRX Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRX Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRX Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRX Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.